Viewing Study NCT03290950

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-01-16 @ 5:33 AM
Study NCT ID: NCT03290950
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-15
First Post: 2017-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Daratumumab View
None Carfilzomib View
None Lenalidomide View
None Dexamethasone View
None 17-352 View